Skip to main content
Log in

Pediatric rhabdomyosarcoma in India: A single-center experience

  • Research Paper
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Objective

Analyze the profile and outcome of children with rhabdomyosarcoma from a pediatric-oncology unit.

Design

Retrospective analysis of case records over 23 years (1990–2012).

Setting

Government-run, tertiary-care, university hospital in Northern India.

Participants

159 children (<12-years) with a diagnosis of rhabdomyosarcoma were enrolled. The median age was 4 years; 13% were infants.

Main outcome measure

Five-year event free survival.

Results

The median symptom interval was 2-months. Head and neck region was the most frequent site (44%), followed by tumors in the extremity (15.7%). The majority (67%) of the tumors were located at ‘unfavorable’ sites; 68% were >5 cm in size. The most frequent (58%) pathological subtype was embryonal. Treatment was based on the ‘Intergroup Rhabdomyosarcoma Study (IRS) Group’ risk-stratification. 33% were ‘low-risk’ children, 11% were ‘high-risk’. Treatment-refusal (18%) and abandonment (33%) were major impediments. The median ± SE five-year event free survival of those taking treatment was 43.6 ± 6%.

Conclusions

Large sized tumors, tumors at unfavorable locations, and treatment refusal/abandonment contributed to inferior outcome in children with rhabdomyosarcoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wexler LH, Meyer WH, Helman LJ. Rhabdomyosarcoma. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2011. p.923.

  2. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al; EUROCARE Working Group. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5–a population-based study. Lancet Oncol. 2014;15:35–47.

    Article  PubMed  Google Scholar 

  3. Raney RB, Anderson JR, Barr FG, Donaldson SS, Pappo AS, Qualman SJ, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of intergroup rhabdomyosarcoma study group experience and rationale for intergroup rhabdomyosarcoma study V. J Pediatr Hematol Oncol. 2001;23:215–20.

    Article  CAS  PubMed  Google Scholar 

  4. Thavaraj V, Kumar R, Dawar R, Gupta DK, Mohanti BK, Singh R, et al. Treatment outcome and survival of rhabdomyosarcoma (RMS) in children. Med Pediatr Oncol. 2001;37:286.

    Google Scholar 

  5. Mehta P, Swami A, Chaphekar M, Currimbhoy Z, Agarwal B. Soft tissue sarcoma (STS): Perspective from a paediatric cancer unit (PCU) at a trust hospital in Mumbai, India. Pediatr Blood Cancer. 2004;43:475.

    Google Scholar 

  6. Dua V, Yadav SP, Prakash A, Sachdeva A. Encouraging treatment outcomes of pediatric rhabdomyosarcoma: a developing world experience. Pediatr Hematol Oncol. 2012;29:677–8.

    Article  PubMed  Google Scholar 

  7. Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children’s Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer. 2012;59:5–10.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Womer RB, Barr FG, Linardic CM. Rhabdomyosarcoma. In: Orkin SH, Fisher DE, Ginsburg D, Thomas Look A, Lux SE, Nathan DG. Nathan and Oski’s Hematology and Oncology of Infancy and Childhood. 8th ed. Philadelphia: Elsevier Saunders; 2015. p.1929.

  9. Ferrari A, Casanova M, Bisogno G, Zanetti I, Cecchetto G, De Bernardi B, et al. Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group. Cancer. 2003;97:2597–604.

    Article  PubMed  Google Scholar 

  10. Ognjanovic S, Linabery AM, Charbonneau B, Ross JA. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975–2005. Cancer. 2009;115:4218–26.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ferrari A, Miceli R, Casanova M, Meazza C, Favini F, Luksch R, et al. The symptom interval in children and adolescents with soft tissue sarcomas. Cancer. 2010;116:177–83.

    PubMed  Google Scholar 

  12. Ferrari A, Lo Vullo S, Giardiello D, Veneroni L, Magni C, Clerici CA, et al. The Sooner the better? How symptom interval correlates with outcome in children and adolescents with solid tumors: Regression Tree analysis of the findings of a prospective study. Pediatr Blood Cancer. 2016;63: 479–85.

    Article  PubMed  Google Scholar 

  13. Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol. 2009;27:3391–7.

    Article  PubMed  Google Scholar 

  14. Maurer HM, Gehan EA, Beltangady M, Veneroni L, Magni C, Clerici CA, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer. 1993;71:1904–22

    Article  CAS  PubMed  Google Scholar 

  15. Uba FA, Chirdan LB. Clinical characteristics and outcome of surgical treatment of childhood rhabdomyosarcoma: A 7- year experience. Afr J Paediatr Surg. 2008;5:19–23.

    Article  PubMed  Google Scholar 

  16. Salman M, Tamim H, Medlej F, El-Ariss T, Saad F, Boulos F, et al. Rhabdomyosarcoma treatment and outcome at a multidisciplinary pediatric cancer center in Lebanon. Pediatr Hematol Oncol. 2012;29:322–34.

    Article  PubMed  Google Scholar 

  17. Ma X, Huang D, Zhao W, Sun L, Xiong H, Zhang Y, et al. Clinical characteristics and prognosis of childhood rhabdomyosarcoma: A ten-year retrospective multicenter study. Int J Clin Exp Med. 2015;8:17196–205.

    PubMed  PubMed Central  Google Scholar 

  18. Park JA, Kim EK, Kang HJ, Shin HY, Kim IH, Ahn HS. Initial response to treatment was highly associated with the prognosis of childhood rhabdomyosarcoma: a retrospective analysis of a single center experience in Korea. Cancer Res Treat. 2008;40:111–5.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Aung L, Soe TA, Chang KT, Quah TC. Singapore rhabdomyosarcoma (RMS) experience: Shall we change our practice? Ann Acad Med Singapore. 2014;43:86–95.

    PubMed  Google Scholar 

  20. Arora RS, Pizer B, Eden T. Understanding refusal and abandonment in the treatment of childhood cancer. Indian Pediatr. 2010;47:1005–10.

    Article  CAS  PubMed  Google Scholar 

  21. Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007;49:941–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepak Bansal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bansal, D., Das, A., Trehan, A. et al. Pediatric rhabdomyosarcoma in India: A single-center experience. Indian Pediatr 54, 735–738 (2017). https://doi.org/10.1007/s13312-017-1164-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-017-1164-5

Keywords

Navigation